» Articles » PMID: 35864503

Functional Interplay Between Long Non-coding RNAs and Breast CSCs

Overview
Journal Cancer Cell Int
Publisher Biomed Central
Date 2022 Jul 21
PMID 35864503
Authors
Affiliations
Soon will be listed here.
Abstract

Breast cancer (BC) represents aggressive cancer affecting most women's lives globally. Metastasis and recurrence are the two most common factors in a breast cancer patient's poor prognosis. Cancer stem cells (CSCs) are tumor cells that are able to self-renew and differentiate, which is a significant factor in metastasis and recurrence of cancer. Long non-coding RNAs (lncRNAs) describe a group of RNAs that are longer than 200 nucleotides and do not have the ability to code for proteins. Some of these lncRNAs can be mainly produced in various tissues and tumor forms. In the development and spread of malignancies, lncRNAs have a significant role in influencing multiple signaling pathways positively or negatively, making them promise useful diagnostic and prognostic markers in treating the disease and guiding clinical therapy. However, it is not well known how the interaction of lncRNAs with CSCs will affect cancer development and progression.Here, in this review, we attempt to summarize recent findings that focus on lncRNAs affect cancer stem cell self-renewal and differentiation in breast cancer development and progression, as well as the strategies and challenges for overcoming lncRNA's therapeutic resistance.

Citing Articles

A review on the role of HAND2-AS1 in cancer.

Ghafouri-Fard S, Hussen B, Abdullah S, Dadyar M, Taheri M, Kiani A Clin Exp Med. 2023; 23(7):3179-3188.

PMID: 37204522 PMC: 10618356. DOI: 10.1007/s10238-023-01092-3.


A review on the role of LINC00511 in cancer.

Ghafouri-Fard S, Safarzadeh A, Hussen B, Taheri M, Ayatollahi S Front Genet. 2023; 14:1116445.

PMID: 37124625 PMC: 10140539. DOI: 10.3389/fgene.2023.1116445.


A review on the role of long non-coding RNA prostate androgen-regulated transcript 1 (PART1) in the etiology of different disorders.

Ghafouri-Fard S, Harsij A, Hussen B, Abdullah S, Baniahmad A, Taheri M Front Cell Dev Biol. 2023; 11:1124615.

PMID: 36875771 PMC: 9974648. DOI: 10.3389/fcell.2023.1124615.


Recent advances in photothermal therapy-based multifunctional nanoplatforms for breast cancer.

Sun J, Zhao H, Xu W, Jiang G Front Chem. 2022; 10:1024177.

PMID: 36199665 PMC: 9528973. DOI: 10.3389/fchem.2022.1024177.

References
1.
Wang D, Wang Z, Zhang L, Sun S . LncRNA PDCD4-AS1 alleviates triple negative breast cancer by increasing expression of IQGAP2 via miR-10b-5p. Transl Oncol. 2020; 14(1):100958. PMC: 7704410. DOI: 10.1016/j.tranon.2020.100958. View

2.
Rosenlund I, Calin G, Dragomir M, Knutsen E . CRISPR/Cas9 to Silence Long Non-Coding RNAs. Methods Mol Biol. 2021; 2348:175-187. DOI: 10.1007/978-1-0716-1581-2_12. View

3.
Cantile M, di Bonito M, Cerrone M, Collina F, De Laurentiis M, Botti G . Long Non-Coding RNA in Breast Cancer Therapy. Cancers (Basel). 2020; 12(5). PMC: 7281113. DOI: 10.3390/cancers12051197. View

4.
Eades G, Wolfson B, Zhang Y, Li Q, Yao Y, Zhou Q . lincRNA-RoR and miR-145 regulate invasion in triple-negative breast cancer via targeting ARF6. Mol Cancer Res. 2014; 13(2):330-8. PMC: 4336811. DOI: 10.1158/1541-7786.MCR-14-0251. View

5.
Wang K, Chang H . Molecular mechanisms of long noncoding RNAs. Mol Cell. 2011; 43(6):904-14. PMC: 3199020. DOI: 10.1016/j.molcel.2011.08.018. View